Combined Use of a Sulfated Glycosaminoglycan and a Hyaluronidase for Improving the Bioavailability of Factor VIII

• 收藏
• 分享

专利权人:

发明人:

Sabine Zollner,Hubert Metzner

申请号：

US14351502

公开号：

US20150023946A1

申请日:

2012.10.18

申请国别(地区):

US

年份:

2015

代理人:

摘要：

The present invention relates to pharmaceutical preparations comprising Factor VIII, a sulfated glycosaminoglycan and a hyaluronidase for the non-intravenous administration in the therapy and prophylactic treatment of bleeding disorders. The invention further relates to the combined use of a Factor VIII, a sulfated glycosaminoglycan and a hyaluronidase for the treatment and prevention of bleeding disorders, and to a method for increasing the bioavailability after non-intravenous administration of Factor VIII by co-adminstration of a sulfated glycosaminoglycan and a hyaluronidase.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/